Press Coverage
Sofinnova Crossover
Tom Burt, partner at Sofinnova Partners, speaks at Edison Group’s Open House Global Healthcare Event
Related Strategy
CrossoverTom Burt, partner at Sofinnova Partners, joined Edison Group’s Open House Global Healthcare Event. His panel discussed some of the scenarios that are likely to play out in 2022 for biotech in public and private equity markets and M&A. View the replay here.
Related News
Sensorion Announces Leadership Changes
Artios Strengthens Leadership Team to Accelerate Late-Stage Development of Potential First-in-Class Oncology Pipeline
European Life Sciences Coalition launched to strengthen Europe’s life sciences investment ecosystem
Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis
The 15-20 National Hospital and GenSight Biologics announce the treatment of the first patient in the GS010/LUMEVOQ® REVISE Study